JAGUAR HEALTH, INC. Goodwill
JAGUAR HEALTH, INC. (JAGX) had Goodwill of $5.21 million as of 2018-12-31, per its 10-K filed 2020-04-03.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:Goodwill · last filed 2020-04-03
- 2018-12-31: Goodwill $5.21M.
- 2018-09-30: Goodwill $5.21M.
- 2018-06-30: Goodwill $5.21M.
- 2018-03-31: Goodwill $5.21M.
| Period end | Goodwill |
|---|---|
| 2018-12-31 | $5.21M 10-K · filed 2020-04-03 |
| 2018-09-30 | $5.21M 10-Q · filed 2018-11-19 |
| 2018-06-30 | $5.21M 10-Q · filed 2018-08-13 |
| 2018-03-31 | $5.21M 10-Q · filed 2018-05-15 |
| 2017-12-31 | $5.21M 10-Q · filed 2019-11-14 |
| 2017-09-30 | $18.39M 10-Q · filed 2017-11-20 |
| 2016-12-31 | $0.00 10-Q · filed 2018-11-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |